Adapthealth Corp AHCO.OQ reported quarterly adjusted earnings of 16 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 15 cents. The mean expectation of eight analysts for the quarter was for earnings of 24 cents per share. Wall Street expected results to range from 19 cents to 29 cents per share.
Revenue rose 1.8% to $820.31 million from a year ago; analysts expected $799.31 million.
Adapthealth Corp's reported EPS for the quarter was 16 cents.
The company reported quarterly net income of $24.51 million.
Adapthealth Corp shares had risen by 1.6% this quarter and lost 4.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 14.5% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Adapthealth Corp is $13.00, about 30.1% above its last closing price of $9.09
This summary was machine generated from LSEG data November 4 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2025 | 0.24 | 0.16 | Missed |
Jun. 30 2025 | 0.12 | -0.13 | Missed |
Mar. 31 2025 | 0.00 | -0.05 | Missed |
Dec. 31 2024 | 0.25 | 0.34 | Beat |